Comprehensive Services
CEDRA's clinical expertise ranges from assistance with initial study design all the way to preparation and submission of final reports.
Our site is GCP/ICH compliant, with all the essential requirements for storing and dispensing study drugs, along with maintaining regulatory documents and study data.
And, our affiliation with CEDRA Corporation's Bioanalytical services allows us to offer our clients seamless transfer of specimens and sample analysis, improving study efficiencies.
The team at CEDRA Clinical Research is comprised of dedicated individuals with significant experience across a broad range of therapeutic areas. Ongoing training and continuing education keep our staff's skills up-to-date.
Our coordinators are supported by a staff of phlebotomists, paramedics, medical technologists, medical assistants, and nurses.
A high retention rate of our key employees has allowed our staff to cultivate exceptionally strong teamwork over the years, which provides consistency and continuity that benefit our sponsors and their studies.
Effortless Enrollment
CEDRA's sophisticated patient and volunteer database, targeted advertising programs and a large pool of prospective study participants enable us to quickly screen subjects and enroll studies.
Austin is home to the University of Texas—the nation's largest public university—and six other area colleges. The city boasts a combined enrollment of nearly 100,000 students, and a demographically diverse metropolitan population of more than one million. And, because Austin is a center for clinical research activity in the U.S., study participants are typically knowledgeable, reliable and compliant with study requirements.
With a diverse array of over 1.1 million people, San Antonio offers large populations of target specific groups such as Hispanics, seniors, and college students. And, with three strong allergy seasons throughout the year, San Antonio is also one of the major allergy centers in the U.S.
Phase I study capabilities include
- Bioavailability
- Bioequivalence
- Bleeding Times
- Dose Ranging
- Drug/drug interactions
- First Time in Man
- Multiple dose tolerance
- Pharmacodynamics
- Pharmacokinetics
- Radiolabel studies
